$IVAC
INTEVAC INC Stock $ivac

$ivac Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-Q Financial Statement

#000119312517327156 Filed on October 31, 2017

Income Statement

Concept	2017 Q4	2017 Q3	2016 Q4
Revenue	$24.77M	$30.96M	$28.98M
YoY Change	-14.54%	107.55%	57.36%
Cost Of Revenue	$14.92M	$15.43M	$14.04M
YoY Change	6.24%	75.5%	3.98%
Gross Profit	$9.847M	$11.30M	$11.91M
YoY Change	-17.34%	84.4%	142.51%
Gross Profit Margin	39.76%	36.49%	41.1%
Selling, General & Admin	$5.830M	$5.495M	$4.772M
YoY Change	22.17%	10.85%	0.76%
% of Gross Profit	59.21%	48.64%	40.06%
Research & Development	$4.090M	$4.535M	$4.067M
YoY Change	0.57%	-8.88%	2.81%
% of Gross Profit	41.54%	40.14%	34.14%
Depreciation & Amortization	$1.000M	$950.0K	$1.080M
YoY Change	-7.41%	-35.81%	-4.42%
% of Gross Profit	10.16%	8.41%	9.07%
Operating Expenses	$9.920M	$10.03M	$8.839M
YoY Change	12.23%	0.97%	1.69%
Operating Profit	-$73.00K	$1.268M	-$324.0K
YoY Change	-77.47%	-133.31%	-91.43%
Interest Expense	$30.00K	$28.00K	$60.00K
YoY Change	-50.0%	-67.82%	160.87%
% of Operating Profit		2.21%
Other Income/Expense, Net	$80.00K		$180.0K
YoY Change	-55.56%
Pretax Income	$260.0K	$1.296M	-$264.0K
YoY Change	-198.48%	-134.84%	-92.97%
Income Tax	-$1.500M	$66.00K	$217.0K
% Of Pretax Income	-576.92%	5.09%
Net Earnings	-$41.00K	$1.230M	$2.835M
YoY Change	-101.45%	-135.24%	-175.42%
Net Earnings / Revenue	-0.17%	3.97%	9.78%
Basic Earnings Per Share	$0.00	$0.06	$0.14
Diluted Earnings Per Share	$0.00	$0.05	$0.13
COMMON SHARES
Basic Shares Outstanding	21.79M shares	21.71M shares	20.87M shares
Diluted Shares Outstanding		22.97M shares	20.87M shares

Balance Sheet

Concept	2017 Q4	2017 Q3	2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$35.60M	$33.80M	$36.60M
YoY Change	-2.73%	-4.52%	-22.29%
Cash & Equivalents	$19.94M	$19.20M	$27.04M
Short-Term Investments	$15.70M	$16.00M	$15.80M
Other Short-Term Assets	$1.001M	$1.024M	$997.0K
YoY Change	0.4%	-10.72%	-5.14%
Inventory	$33.79M	$32.58M	$24.88M
Prepaid Expenses
Receivables	$20.50M	$26.60M	$19.00M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$92.43M	$94.95M	$88.74M
YoY Change	4.16%	24.44%	13.76%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.48M	$12.51M	$11.24M
YoY Change	11.04%	6.67%	-5.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$6.800M	$7.600M	$4.300M
YoY Change	58.14%	46.15%	-41.1%
Other Assets	$1.800M	$2.100M	$871.0K
YoY Change	106.66%	128.51%	-39.35%
Total Long-Term Assets	$22.59M	$22.48M	$19.59M
YoY Change	15.35%	0.53%	-24.32%
TOTAL ASSETS
Total Short-Term Assets	$92.43M	$94.95M	$88.74M
Total Long-Term Assets	$22.59M	$22.48M	$19.59M
Total Assets	$115.0M	$117.4M	$108.3M
YoY Change	6.18%	19.02%	4.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.949M	$7.036M	$5.323M
YoY Change	-25.81%	74.16%	25.75%
Accrued Expenses	$7.688M	$7.856M	$17.01M
YoY Change	-54.81%	117.2%	346.95%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$29.48M	$33.02M	$31.98M
YoY Change	-7.8%	22.49%	99.08%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.879M	$2.994M	$3.082M
YoY Change	-6.59%	3.85%	22.84%
Total Long-Term Liabilities	$2.879M	$2.994M	$3.082M
YoY Change	-6.59%	3.85%	22.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$29.48M	$33.02M	$31.98M
Total Long-Term Liabilities	$2.879M	$2.994M	$3.082M
Total Liabilities	$32.36M	$36.01M	$35.06M
YoY Change	-7.7%	20.69%	88.78%
SHAREHOLDERS EQUITY
Retained Earnings	-$66.88M	-$66.84M	-$69.90M
YoY Change	-4.32%	-7.49%	16.63%
Common Stock	$177.5M	$176.3M	$171.3M
YoY Change	3.62%	4.27%	3.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$28.49M	$28.49M	$28.49M
YoY Change	0.0%	0.0%	36.07%
Treasury Stock Shares	$4.845M	4.845M shares	4.845M shares
Shareholders Equity	$82.66M	$81.42M	$73.27M
YoY Change
Total Liabilities & Shareholders Equity	$115.0M	$117.4M	$108.3M
YoY Change	6.18%	19.02%	4.28%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2016 Q4
OPERATING ACTIVITIES
Net Income	-$41.00K	$1.230M	$2.835M
YoY Change	-101.45%	-135.24%	-175.42%
Depreciation, Depletion And Amortization	$1.000M	$950.0K	$1.080M
YoY Change	-7.41%	-35.81%	-4.42%
Cash From Operating Activities	-$640.0K	-$2.040M	$1.260M
YoY Change	-150.79%	9.68%	-313.56%
INVESTING ACTIVITIES
Capital Expenditures	-$810.0K	-$1.100M	-$500.0K
YoY Change	62.0%	39.24%	-25.37%
Acquisitions
YoY Change
Other Investing Activities	$1.630M	-$2.550M	$590.0K
YoY Change	176.27%	1114.29%	-86.65%
Cash From Investing Activities	$840.0K	-$3.650M	$80.00K
YoY Change	950.0%	268.69%	-97.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	80.00K	-410.0K	770.0K
YoY Change	-89.61%	127.78%	-162.6%
NET CHANGE
Cash From Operating Activities	-640.0K	-2.040M	1.260M
Cash From Investing Activities	840.0K	-3.650M	80.00K
Cash From Financing Activities	80.00K	-410.0K	770.0K
Net Change In Cash	280.0K	-6.100M	2.110M
YoY Change	-86.73%	101.32%	9.33%
FREE CASH FLOW
Cash From Operating Activities	-$640.0K	-$2.040M	$1.260M
Capital Expenditures	-$810.0K	-$1.100M	-$500.0K
Free Cash Flow	$170.0K	-$940.0K	$1.760M
YoY Change	-90.34%	-12.15%	2100.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	30000000
CY2017Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	21789007	shares
CY2016Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	592000
CY2016Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	748000
CY2017Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1220000
CY2017Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	859000
CY2016Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	722000
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	800000
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20823000
CY2017Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	4845000	shares
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2127940	shares
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.16
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2976413	shares
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.64
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-66840000
CY2017Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2994000
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	117432000
CY2017Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5781000
CY2017Q3	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	404000
CY2017Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	443000
CY2017Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	7036000
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	81418000
CY2017Q3	us-gaap	Common Stock Value CommonStockValue	22000
CY2017Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	176282000
CY2017Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	1500000
CY2017Q3	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	915000
CY2017Q3	us-gaap	Standard Product Warranty Accrual Noncurrent StandardProductWarrantyAccrualNoncurrent	220000
CY2017Q3	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	1400000
CY2017Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6725000
CY2017Q3	us-gaap	Customer Advances Current CustomerAdvancesCurrent	12347000
CY2017Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2000
CY2017Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2017Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1135000
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	33020000
CY2017Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	404000
CY2017Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7856000
CY2017Q3	us-gaap	Assets Current AssetsCurrent	94951000
CY2017Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	11753000
CY2017Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	3000
CY2017Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	16000
CY2017Q3	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	745000
CY2017Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	12452000
CY2017Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1024000
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12509000
CY2017Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1400000
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	321000
CY2017Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	22311000
CY2017Q3	us-gaap	Assets Assets	117432000
CY2017Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	1697000
CY2017Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	43413000
CY2017Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	29240000
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	23082000
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	23075000
CY2017Q3	us-gaap	Debt Instrument Collateral Amount DebtInstrumentCollateralAmount	1400000
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	615000
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	615000
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	29254000
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19197000
CY2017Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	4000
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	159000
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	273000
CY2017Q3	us-gaap	Inventory Net InventoryNet	32581000
CY2017Q3	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	6165000
CY2017Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	43399000
CY2017Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	13000
CY2017Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	724000
CY2017Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	18037000
CY2017Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1662000
CY2017Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8387000
CY2017Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	3744000
CY2017Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	16385000
CY2017Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2825000
CY2017Q3	us-gaap	Treasury Stock Value TreasuryStockValue	28489000
CY2017Q3	ivac	Common Property Plant And Equipment CommonPropertyPlantAndEquipment	1698000
CY2017Q3	ivac	Availableforsale Securities Debt Maturities After One Through Two Years Amortized Cost AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsAmortizedCost	6172000
CY2017Q3	ivac	Available For Sale Securities Debt Maturities After One Through Two Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue	6165000
CY2016Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	982000
CY2016Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	890000
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13746000
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	4845000	shares
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2740364	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.00
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-69901000
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3082000
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	108324000
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4220000
CY2016Q4	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	759000
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.50
CY2016Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1007000
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5323000
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	73266000
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	21000
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	171314000
CY2016Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	829000
CY2016Q4	us-gaap	Standard Product Warranty Accrual Noncurrent StandardProductWarrantyAccrualNoncurrent	178000
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6129000
CY2016Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent	5422000
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1000
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	31976000
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	759000
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17011000
CY2016Q4	us-gaap	Assets Current AssetsCurrent	88736000
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	23000
CY2016Q4	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	898000
CY2016Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	6470000
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	997000
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11237000
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1602000
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27043000
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	3000
CY2016Q4	us-gaap	Inventory Net InventoryNet	24876000
CY2016Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	3593000
CY2016Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	48238000
CY2016Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	871000
CY2016Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	17602000
CY2016Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	17447000
CY2016Q4	us-gaap	Assets Assets	108324000
CY2016Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	48260000
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2258000
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	8116000
CY2016Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	10290000
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1768000
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	28489000
CY2016Q4	ivac	Common Property Plant And Equipment CommonPropertyPlantAndEquipment	1039000
CY2017Q1	us-gaap	New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Equity Or Net Assets1 NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1	1100000
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.50
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3052000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20704000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20704000	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	9042000
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	0
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1482000
	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	-370000
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	494000
	us-gaap	Sales Revenue Net SalesRevenueNet	51142000
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	5000
	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	46000
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	184000
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	8000
	us-gaap	Contracts Revenue ContractsRevenue	3816000
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-96000
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	47326000
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	10433000
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	2535000
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	46000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10447000
	us-gaap	Net Income Loss NetIncomeLoss	-10276000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10230000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	403000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	41000
	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-577000
	us-gaap	Gross Profit GrossProfit	18497000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-90000
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	46000
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	178000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10263000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-90000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	9000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3744000
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	8000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13000
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	22180000
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	8000
	us-gaap	Share Based Compensation ShareBasedCompensation	2896000
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	7224000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14724000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	32645000
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1079000
	us-gaap	Product Warranty Expense ProductWarrantyExpense	384000
	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	0
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14220000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	7077000
	us-gaap	Contract Revenue Cost ContractRevenueCost	3155000
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	29490000
	us-gaap	Operating Expenses OperatingExpenses	28944000
	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div> <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr style="page-break-inside:avoid"> <td width="4%" valign="top" align="left"><b>2.</b></td> <td align="left" valign="top"><b>Recent Accounting Pronouncements</b></td> </tr> </table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> In May 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) <font style="white-space:nowrap">2017-09,</font> <i>Compensation—Stock Compensation: Scope of Modification Accounting</i>, which provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. An entity will account for the effects of a modification unless the fair value of the modified award is the same as the original award, the vesting conditions of the modified award are the same as the original award and the classification of the modified award as an equity instrument or liability instrument is the same as the original award. This update becomes effective and will be adopted by Intevac in the first quarter of fiscal 2019. The update is to be adopted prospectively to an award modified on or after the adoption date. Early adoption is permitted. Intevac does not expect the adoption of this update to have a material impact on its consolidated financial statements.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> In March 2017, the FASB issued ASU <font style="white-space:nowrap">2017-08,</font> <i>Receivables – Nonrefundable Fees and Other Costs (Subtopic <font style="white-space:nowrap">310-20):</font> Premium Amortization on Purchased Callable Debt Securities</i>. ASU <font style="white-space:nowrap">2017-08</font> amends the amortization period for certain purchased callable debt securities held at a premium, shortening such period to the earliest call date. This update becomes effective and will be adopted by Intevac in the first quarter of fiscal 2019. Intevac does not expect the adoption of this update to have a material impact on its consolidated financial statements.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> In January 2017, the FASB issued ASU <font style="white-space:nowrap">2017-04,</font> <i>Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment</i>. ASU <font style="white-space:nowrap">2017-04</font> eliminates Step 2 from the goodwill impairment test. Under Step 2, an entity had to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination. Instead, under the amendments in ASU <font style="white-space:nowrap">2017-04,</font> an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Additionally, an entity should consider income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. This update becomes effective and will be adopted by Intevac in the first quarter of fiscal 2020. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. Intevac does not expect the adoption of this update to have a material impact on its consolidated financial statements.</p> <p style="font-size:1px;margin-top:12px;margin-bottom:0px">  </p> <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> In March 2016, the FASB issued ASU <font style="white-space:nowrap">2016-09</font> <i>Compensation—Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting</i>. We have adopted these amendments beginning in the first quarter of 2017. Starting in the first quarter of fiscal 2017, stock-based compensation excess tax benefits or deficiencies are reflected in the Condensed Consolidated Statements of Operations as a component of the provision for income taxes, whereas they previously were recognized in equity. Additionally, our Condensed Consolidated Statements of Cash Flows now presents excess tax benefits as an operating activity. Finally, we have elected to account for forfeitures as they occur, rather than estimate expected forfeitures. The net cumulative effect of this change was recognized as a $1.1 million charge to the accumulated deficit as of January 1, 2017.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> In May 2014, the FASB issued ASU <font style="white-space:nowrap">2014-09</font> <i>(Topic 606) Revenue from Contracts with Customers.</i> Topic 606 supersedes the revenue recognition requirements in Accounting Standards Codification Topic 605, “Revenue Recognition”, and requires entities to recognize revenue when they transfer control of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. We expect revenue recognition for our equipment sales arrangements, which includes systems, technology upgrades, service and spare parts, to remain materially consistent with our historical practice.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> We expect to recognize revenue for equipment sales at a point in time following the transfer of control of such products to the customer, which typically occurs upon shipment or delivery depending on the terms of the underlying contracts. Our contracts with customers may include multiple performance obligations. For such arrangements, we expect to allocate revenue to each performance obligation based on its relative standalone selling price. We generally determine standalone selling prices based on the prices charged to customers or using expected cost plus margin. The expected costs associated with our base warranties will continue to be recognized as expense when the equipment is sold.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> We expect to recognize revenue for cost plus fixed fee and firm fixed priced government contracts over time under the <font style="white-space:nowrap"><font style="white-space:nowrap">cost-to-cost</font></font> method for the majority of our government contracts, which is consistent with our current revenue recognition model. Revenue on the majority of our government contracts will continue to be recognized over time because of the continuous transfer of control to the customer. For U.S. government contracts, this continuous transfer of control to the customer is supported by clauses in the contract that allow the customer to unilaterally terminate the contract for convenience, pay us for costs incurred plus a reasonable profit and take control of any work in process. Similarly, for <font style="white-space:nowrap">non-U.S.</font> government contracts, the customer typically controls the work in process as evidenced either by contractual termination clauses or by our rights to payment for work performed to date to deliver products or services that do not have an alternative use to the company. Under the new standard, the <font style="white-space:nowrap"><font style="white-space:nowrap">cost-to-cost</font></font> measure of progress continues to best depict the transfer of control of assets to the customer, which occurs as we incur costs.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> The new standard must be adopted by Intevac in our fiscal year beginning December 31, 2017. We intend to adopt the new standard as of December 31, 2017, using the modified retrospective transition method applied to those contracts which were not completed as of that date. Upon adoption, we will recognize the cumulative effect of adopting this guidance as an adjustment to our opening balance of the accumulated deficit. Prior periods will not be retrospectively adjusted. Based on our preliminary assessment, we expect the adoption of Topic 606 will not have a material impact to our consolidated financial statements, including the presentation of revenues in our Consolidated Statements of Operations. We also do not expect the standard to have a material impact on our Consolidated Balance Sheet. The immaterial impact primarily relates to reclassifications among financial statement accounts to align with the new standard. Most notably, contracts in process, net will be reclassified as receivables or contract assets based on amounts billed or unbilled, respectively. Advance payments and billings in excess of costs incurred and deferred revenue will be combined and reclassified as contract liabilities. Our contract balances will be reported in a net contract asset or liability position on a <font style="white-space:nowrap"><font style="white-space:nowrap">contract-by-contract</font></font> basis at the end of each reporting period.</p> </div>
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Type DocumentType	10-Q
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
	dei	Entity Central Index Key EntityCentralIndexKey	0001001902
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1739000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	6.88
	dei	Trading Symbol TradingSymbol	IVAC
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22989000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21475000	shares
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Gross Profit GrossProfit	35816000
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.85	pure
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	12.07
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	12.33
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	61753	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1514000	shares
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
	dei	Document Period End Date DocumentPeriodEndDate	2017-09-30
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	413075	shares
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	405659	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	115273	shares
	us-gaap	Average Remaining Maturity Of Foreign Currency Derivatives1 AverageRemainingMaturityOfForeignCurrencyDerivatives1	P30D
	dei	Entity Registrant Name EntityRegistrantName	INTEVAC INC
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-181000
	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	93000
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	675000
	us-gaap	Sales Revenue Net SalesRevenueNet	88077000
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	114000
	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	122000
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	265000
	us-gaap	Contracts Revenue ContractsRevenue	5255000
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-53000
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	82822000
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	21968000
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	3553000
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	122000
	us-gaap	Operating Income Loss OperatingIncomeLoss	4699000
	us-gaap	Net Income Loss NetIncomeLoss	4159000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4281000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1988000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	8000
	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	11658000
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	122000
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-202000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4964000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-181000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2877000
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	114000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	805000
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-6403000
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	0
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2344000
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	18916000
	us-gaap	Share Based Compensation ShareBasedCompensation	3012000
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-5898000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	17482000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	52261000
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	182000
	us-gaap	Product Warranty Expense ProductWarrantyExpense	640000
	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	0
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13635000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	596000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-7846000
	us-gaap	Contract Revenue Cost ContractRevenueCost	4842000
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	47419000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	174000
	us-gaap	Operating Expenses OperatingExpenses	31117000
	ivac	Purchase Intervals Of Series PurchaseIntervalsOfSeries	P6M
	ivac	Share Based Compensation Arrangement By Share Based Payment Award Conversion Ratio ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRatio	1.00	pure
	ivac	Minimum Product Warranty Range MinimumProductWarrantyRange	P12M
	ivac	Payment Of Acquisition Related Contingent Consideration PaymentOfAcquisitionRelatedContingentConsideration	174000
	ivac	Maximum Product Warranty Range MaximumProductWarrantyRange	P24M
CY2016Q4	us-gaap	Product Warranty Expense ProductWarrantyExpense	80000
CY2016Q4	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	0
CY2016Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4067000
	ivac	Maximum Employee Salary Withholdings For Purchase Of Common Stock Under Terms Of Espp MaximumEmployeeSalaryWithholdingsForPurchaseOfCommonStockUnderTermsOfEspp	0.15	pure
	ivac	Share Based Compensation Arrangement By Share Based Payment Award Options Offering Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOfferingPeriod	P2Y
	ivac	Allocation Of Corporate Expenses To Segments AllocationOfCorporateExpensesToSegments	0.03	pure
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2016Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20869000	shares
CY2016Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20869000	shares
CY2016Q4	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2016Q4	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	-110000
CY2016Q4	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	320000
CY2016Q4	us-gaap	Sales Revenue Net SalesRevenueNet	22559000
CY2016Q4	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	-17000
CY2016Q4	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	-33000
CY2016Q4	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	60000
CY2016Q4	us-gaap	Contracts Revenue ContractsRevenue	1598000
CY2016Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	20961000
CY2016Q4	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-33000
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-324000
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	-481000
CY2016Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-514000
CY2016Q4	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-16000
CY2016Q4	us-gaap	Gross Profit GrossProfit	8515000
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	52000
CY2016Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-33000
CY2016Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-264000
CY2016Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	217000
CY2016Q4	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	0
CY2016Q4	us-gaap	Share Based Compensation ShareBasedCompensation	905000
CY2016Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4772000
CY2016Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	14044000
CY2016Q4	us-gaap	Contract Revenue Cost ContractRevenueCost	1019000
CY2016Q4	us-gaap	Cost Of Goods Sold CostOfGoodsSold	13025000
CY2016Q4	us-gaap	Operating Expenses OperatingExpenses	8839000
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22970000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21714000	shares
CY2017Q3	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2017Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1256000	shares
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2017Q3	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	106000
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	66000
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5495000
CY2017Q3	us-gaap	Share Based Compensation ShareBasedCompensation	1148000
CY2017Q3	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	0
CY2017Q3	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	44000
CY2017Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	28000
CY2017Q3	us-gaap	Contracts Revenue ContractsRevenue	2189000
CY2017Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	24537000
CY2017Q3	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	44000
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1268000
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	1230000
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1274000
CY2017Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	5000
CY2017Q3	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	169000
CY2017Q3	us-gaap	Sales Revenue Net SalesRevenueNet	26726000
CY2017Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	39000
CY2017Q3	us-gaap	Gross Profit GrossProfit	11298000
CY2017Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-283000
CY2017Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	44000
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1296000
CY2017Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	15428000
CY2017Q3	us-gaap	Product Warranty Expense ProductWarrantyExpense	360000
CY2017Q3	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	0
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4535000
CY2017Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	169000
CY2017Q3	us-gaap	Contract Revenue Cost ContractRevenueCost	2026000
CY2017Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	13402000
CY2017Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	172000
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	10030000

Files In Submission

Name	View Source	Status
0001193125-17-327156-index-headers.html	Edgar Link	pending
0001193125-17-327156-index.html	Edgar Link	pending
0001193125-17-327156.txt	Edgar Link	pending
0001193125-17-327156-xbrl.zip	Edgar Link	pending
d443897d10q.htm	Edgar Link	pending
d443897dex311.htm	Edgar Link	pending
d443897dex312.htm	Edgar Link	pending
d443897dex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
ivac-20170930.xml	Edgar Link	completed
ivac-20170930.xsd	Edgar Link	pending
ivac-20170930_cal.xml	Edgar Link	unprocessable
ivac-20170930_def.xml	Edgar Link	unprocessable
ivac-20170930_lab.xml	Edgar Link	unprocessable
ivac-20170930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IVAC
INTEVAC INC Stock $ivac

2017 Q4 Form 10-Q Financial Statement

#000119312517327156 Filed on October 31, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IVAC INTEVAC INC Stock $ivac

2017 Q4 Form 10-Q Financial Statement

#000119312517327156 Filed on October 31, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IVAC
INTEVAC INC Stock $ivac